News Archives - Page 66 of 87

MondayNov 14, 2022 12:55 pm

TinyGemsBreaks – Tingo Inc. (TMNA) Announces Strong Q3 2022 Results, Positioned for Continued Growth and Acceleration of Expansion Strategy

Tingo (OTC: TMNA) today announced that it has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three and nine months ended Sept. 30, 2022. Among the highlights, the company reported growth in its Nwassa agri-fintech business that has driven increases of 64.8 % in revenues and 53.9 % in operating profit as compared to Q3 2021. In addition, the company reported that it has filed a definitive Information Statement on Schedule 14C, marking a major milestone towards completion of the merger of Tingo Mobile PLC, the company’s sole operating subsidiary (“Tingo Mobile”),…

MondayNov 14, 2022 12:16 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Partners with 357 Company to Launch Cannabis Division

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is working with the 357 Company to launch 357’s Canna Logistics division. The new division is an expansion beyond 357’s Hemp Logistics segment, which ships federally legal hemp within the United States. According to the announcement, the new division will focus on logistics management and shipping of cannabis and hemp between countries where cannabis has been legalized. 357 is working to expand into international shipping of cannabis, hemp and industrial hemp; the cannabis export/import industry is new and poses significant potential for shipments of…

MondayNov 14, 2022 12:00 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for the treatment of glaucoma. According to the report, enrollment and patient treatment in the company’s phase 2 clinical trial for INM-755 should be complete by the end of the year while the company continues to conduct key preclinical work including toxicology and GLP studies in…

ThursdayNov 10, 2022 4:10 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Robot Show to Take the Spotlight in Portland, Oregon

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at Legacy Emanuel Medical Center in Portland, Oregon, for the Violence in the Workplace Prevention Summit on Nov. 11, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Portland Roadshow landing will be guided by Knightscope experts, and visitors will be able to interact directly with each of the ASRs and see the Knightscope Security Operations Center (‘KSOC’) user…

ThursdayNov 10, 2022 3:46 pm

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Selects Our Next Energy as Battery Supplier for Electric Commercial Trucks

Mullen Automotive’s (NASDAQ: MULN) majority owned company, Bollinger Motors, today announced that Our Next Energy will be supplying modular, linkable Aries battery packs to power its all-electric commercial platforms and chassis cabs. Bollinger’s all-electric Class 4 through Class 6 chassis cabs are designed to meet the needs of commercial customers in a segment that often requires large payloads, sufficient range, durability, and longevity. “ONE battery packs are ideal for our commercial trucks, giving our customers the range they need,” said Robert Bollinger, founder and CEO of Bollinger Motors. “The fact they’ll be built in the U.S. and in Michigan is…

ThursdayNov 10, 2022 2:15 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First-Ever Study Exploring Therapeutic Use of DehydraTECH-CBD in Dementia

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is starting a new study program — DEM-A22-1 — on Nov. 15, 2022. The study, a first for Lexaria, will evaluate whether LEXX’s DehydraTECH-processed cannabidiol (“CBD”) may have potential for therapeutic treatment for dementia. According to the announcement, Lexaria has previously shown the efficacy of DehydraTECH-CBD in studies focused on human hypertension; the studies showed no serious side effects. Lexaria is exploring the potential for dementia based on previous clinical studies that have established connections between hypertension and dementia: specifically, that individuals who have high blood pressure are more likely…

ThursdayNov 10, 2022 1:54 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports Majority of Franchise Global Health (TSX.V: FGH) Shareholders Approve Acquisition

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is one step closer to completing its previously announced acquisition of Franchise Global Health (TSX.V: FGH). FLGC announced that holders of more than 73% of the outstanding shares of FGH have agreed to vote their shares in favor of Flora’s acquisition of FGH; the voting will take place during FGH’s special meeting of shareholders, scheduled for Dec. 13, 2022. The completion of the acquisition remains subject to customary closing conditions, including approval of the plan of arrangement by the Supreme Court of British Columbia…

ThursdayNov 10, 2022 1:27 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in July 2022. “The acquisition of the Phase 1 DMT study was done with an eye toward informing and accelerating the clinical path forward for CYB004, and we are very pleased with the progress so far,”…

ThursdayNov 10, 2022 12:05 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific Time on Nov. 17, 2022. Interested parties should visit https://ibn.fm/5WHrj to register for and join the complimentary, Zoom webinar-based event. Once registered, participants may begin forwarding their questions for InMed’s management to Tribe Public at…

ThursdayNov 10, 2022 11:36 am

TinyGemsBreaks – Tingo Inc. (TMNA) Announces Launch of Operations in Ghana, Entry into Landmark Trade Deal with the Kingdom of Ashanti

Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed on a landmark trade deal with the Kingdom of Ashanti, through the Ashanti Kingdom Investment Trust. Under the terms, the Ashanti Kingdom Investment Trust has committed to enroll a minimum of 2 million new members with Tingo within 120 days of signing and has agreed…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News